|
|
Office Locations:
|
2450 Holcombe Boulevard
Houston, TX 77021
Phone: 318-746-8430
| |
|
|
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
The Cancer Focus Fund is a unique oncology-focused investment fund established in partnership with The University of Texas MD Anderson Cancer Center. The firm invests in promising cancer therapies in late preclinical development. The objective is to provide financial support to accelerate the development of these therapeutics together with the clinical trials expertise and infrastructure of MD Anderson. The Cancer Focus Fund provides both capital and translational research expertise with the goal of accelerating the development of therapies to lead to better outcomes for patients while generating returns for investors. The fund provides investment support to advance promising cancer therapies that are close to being tested in humans or are in early clinical development, as well as the clinical trial expertise and infrastructure of MD Anderson and strategic partners Ochsner Health System Precision Cancer Therapies Program New Orleans and the LSU Feist Weiller Cancer Center Shreveport.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
